Form 4 for EVH Evolent Health, Inc.
Accepted 2026-03-04 00:00:00 ET · period of report 2026-03-01 · accession 0001628908-26-000023 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2026-03-04 | 2026-03-01+ | EVH | Blackley Seth | CEO, Dir | F - Tax | $3.49 | -51.3K | 861.0K | -6% | -$178.9K |
| D | 2026-03-04 | 2026-03-02 | EVH | Blackley Seth | CEO, Dir | A - Grant | $0.00 | +58.9K | 878.8K | +7% | $0 |
| D | 2026-03-04 | 2026-03-02 | EVH | Blackley Seth | CEO, Dir | A - Grant | $0.00 | +1.43M | 1.43M | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2026-03-01 | F | D | 9,537 | $3.25 | 819,830 | D | — | — | (F1) This number represents shares of Class A Common Stock withheld to satisfy the tax withholding obligation due upon vesting of restricted stock units. (F2) Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission. |
| 2 | Common | Class A Common Stock | 2026-03-02 | A | A | 58,921 | $0.00 | 878,751 | D | — | — | (F3) Represents the number of shares received upon the settlement of the performance-based share units (PSUs) awarded to the reporting person on March 1, 2024, following the certification of achievement of specified performance metrics by the Compensation Committee of the Company's Board of Directors on March 2, 2026. The shares underlying the PSU award vested at the conclusion of the performance period on December 31, 2025. (F2) Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission. |
| 3 | Common | Class A Common Stock | 2026-03-03 | F | D | 24,053 | $3.51 | 836,962 | D | — | — | (F1) This number represents shares of Class A Common Stock withheld to satisfy the tax withholding obligation due upon vesting of restricted stock units. (F2) Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission. |
| 4 | Common | Class A Common Stock | 2026-03-02 | F | D | 17,736 | $3.58 | 861,015 | D | — | — | (F4) This number represents shares of Class A Common Stock withheld to satisfy the tax withholding obligation due upon settlement of performance-based share units. (F2) Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission. |
| 5 | Derivative | Performance-Based Share Unit | 2026-03-02 | A | A | 1,425,310 | $0.00 | 1,425,310 | D | — · 2027-03-01 to 2029-02-28 | 1,425,310 Class A Common Stock | (F5) Represents performance-based share units (PSUs) granted to Mr. Blackley pursuant to the Evolent Health, Inc. Amended and Restated 2015 Omnibus Incentive Compensation Plan. The PSUs may be earned based on the achievement of certain stock price performance conditions from March 1, 2027 to February 28, 2029, subject to satisfying certain service-based conditions. Each PSU is shown at the target level, and the actual amount earned after completion of the performance period may range from 0% to 250% of the target level. |